Anders A. F. Sima

Articles in Scholarly Journals [Incomplete List]

  1. The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat
    Experimental Diabetes Research, vol. 2008, Article ID 230458, 13 pages, 2008
  2. C-Peptide Reverses Nociceptive Neuropathy in Type 1 Diabetes
    Diabetes, vol. 55, no. 12, pp. 3581–3587, 2006
  3. C-peptide improves neuropathy in type 1 diabetic BB/Wor-rats
    Diabetes/Metabolism Research and Reviews, vol. 23, no. 1, pp. 63–70, 2006
  4. The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy
    Journal of the Neurological Sciences, vol. 247, no. 2, pp. 217–223, 2006
  5. The role of impaired insulin/IGF action in primary diabetic encephalopathy
    Brain Research, vol. 1037, no. 1-2, pp. 12–24, 2005
  6. Unmyelinated fiber sensory neuropathy differs in type 1 and type 2 diabetes
    Diabetes/Metabolism Research and Reviews, vol. 21, no. 5, pp. 448–458, 2005
  7. Apoptotic Stress Is Counterbalanced by Survival Elements Preventing Programmed Cell Death of Dorsal Root Ganglions in Subacute Type 1 Diabetic BB/Wor Rats
    Diabetes, vol. 54, no. 11, pp. 3288–3295, 2005
  8. The Effect of C-Peptide on Cognitive Dysfunction and Hippocampal Apoptosis in Type 1 Diabetic Rats
    Diabetes, vol. 54, no. 5, pp. 1497–1505, 2005
  9. Acetyl-L-Carnitine Improves Pain, Nerve Regeneration, and Vibratory Perception in Patients With Chronic Diabetic Neuropathy: An analysis of two randomized placebo-controlled trials
    Diabetes Care, vol. 28, no. 1, pp. 89–94, 2005
  10. Molecular Alterations Underlie Nodal and Paranodal Degeneration in Type 1 Diabetic Neuropathy and Are Prevented by C-Peptide
    Diabetes, vol. 53, no. 6, pp. 1556–1563, 2004
  11. C-peptide corrects endoneurial blood flow but not oxidative stress in type 1 BB/Wor rats
    AJP: Endocrinology and Metabolism, vol. 287, no. 3, pp. E497–E505, 2004
  12. Preface
    Experimental Diabesity Research, vol. 5, no. 1, pp. 1–1, 2004
  13. The C-peptide Signaling
    Experimental Diabesity Research, vol. 5, no. 1, pp. 25–36, 2004
  14. Type 1 Diabetic Neuropathy and C-peptide
    Experimental Diabesity Research, vol. 5, no. 1, pp. 65–77, 2004
  15. C-peptide and Central Nervous System Complications in Diabetes
    Experimental Diabesity Research, vol. 5, no. 1, pp. 79–90, 2004
  16. C-peptide and Retinal Microangiopathy in Diabetes
    Experimental Diabesity Research, vol. 5, no. 1, pp. 91–96, 2004
  17. Diabetes underlies common neurological disorders
    Annals of Neurology, vol. 56, no. 4, pp. 459–461, 2004
  18. C-peptide prevents nociceptive sensory neuropathy in type 1 diabetes
    Annals of Neurology, vol. 56, no. 6, pp. 827–835, 2004
  19. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes
    European Journal of Pharmacology, vol. 490, no. 1-3, pp. 187–197, 2004
  20. Corrigendum to “Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes”[Eur. J. Pharmacol. 490 (2004) 187–197]
    European Journal of Pharmacology, vol. 494, no. 1, p. 77, 2004
  21. Diabetic neuropathy in type 1 and type 2 diabetes and the effects of C-peptide
    Journal of the Neurological Sciences, vol. 220, no. 1-2, pp. 133–136, 2004
  22. Diabetes enhances apoptosis induced by cerebral ischemia
    Life Sciences, vol. 76, no. 3, pp. 249–262, 2004
  23. Effects of C-peptide on expression of eNOS and iNOS in human cavernosal smooth muscle cells*1
    Urology, vol. 64, no. 3, pp. 622–627, 2004
  24. New insights into the metabolic and molecular basis for diabetic neuropathy
    Cellular and Molecular Life Sciences (CMLS), vol. 60, no. 11, pp. 2445–2464, 2003
  25. C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells
    Diabetes/Metabolism Research and Reviews, vol. 19, no. 5, pp. 375–385, 2003
  26. The Insulin-Like Growth Factor System and Neurological Complications in Diabetes
    Experimental Diabetes Research, vol. 4, no. 4, pp. 235–256, 2003
  27. Editorial
    International Journal of Experimental Diabetes Research, vol. 3, no. 4, pp. 215–215, 2002
  28. C-peptide Prevents Hippocampal Apoptosis in Type 1 Diabetes
    International Journal of Experimental Diabetes Research, vol. 3, no. 4, pp. 241–245, 2002
  29. GCPII (NAALADase) inhibition prevents long-term diabetic neuropathy in type 1 diabetic BB/Wor rats
    Journal of the Neurological Sciences, vol. 194, no. 1, pp. 21–28, 2002
  30. Expression and localization of insulin receptor in rat dorsal root ganglion and spinal cord
    Journal of the Peripheral Nervous System, vol. 7, no. 1, pp. 44–53, 2002
  31. Impaired glucose tolerance and insulinopenia in the GK-rat causes peripheral neuropathy
    Diabetes/Metabolism Research and Reviews, vol. 18, no. 6, pp. 473–483, 2002
  32. Hippocampal neuronal apoptosis in type 1 diabetes
    Brain Research, vol. 946, no. 2, pp. 221–231, 2002
  33. C-peptide prevents and improves chronic Type I diabetic polyneuropathy in the BB/Wor rat
    Diabetologia, vol. 44, no. 7, pp. 889–897, 2001
  34. Molecular basis for the insulinomimetic effects of C-peptide
    Diabetologia, vol. 44, no. 10, pp. 1247–1257, 2001
  35. Diabetic neuropathy: A heterogeneous, dynamic, and progressive disorder
    Journal of Neuroscience Research, vol. 66, no. 6, pp. 1226–1227, 2001
  36. C-Peptide Attenuates Protein Tyrosine Phosphatase Activity and Enhances Glycogen Synthesis in L6 Myoblasts
    Biochemical and Biophysical Research Communications, vol. 280, no. 3, pp. 615–619, 2001
  37. Neuropathological Correlates of Dysarthria in Progressive Supranuclear Palsy
    Archives of Neurology, vol. 58, no. 2, pp. 265–269, 2001
  38. Neuropathologic Correlates of Dysarthria in Progressive Supranuclear Palsy
    Archives of Neurology, vol. 58, no. 9, pp. 1499–1500, 2001
  39. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation
    Annals of Neurology, vol. 50, no. 3, pp. 358–365, 2001
  40. Diabetic neuropathy: pathogenetic background, current and future therapies
    Expert Review of Neurotherapeutics, vol. 1, no. 2, pp. 225–238, 2001
  41. Ceruloplasmin immunoreactivity in neurodegenerative disorders
    Free Radical Research, vol. 35, no. 2, pp. 111–118, 2001
  42. Editorial
    Experimental Diabetes Research, vol. 2, no. 1, pp. 1–1, 2001
  43. Proinsulin C-peptide - A Consensus Statement
    Experimental Diabetes Research, vol. 2, no. 2, pp. 145–151, 2001
  44. Human C-peptide Dose Dependently Prevents Early Neuropathy in the BB/Wor-rat
    Experimental Diabetes Research, vol. 2, no. 3, pp. 187–193, 2001
  45. Has C-Peptide Come of Age?
    Experimental Diabetes Research, vol. 2, no. 2, pp. 81–82, 2001
  46. Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance
    Diabetic Medicine, vol. 17, no. 4, pp. 259–268, 2000
  47. Editorial
    Experimental Diabetes Research, vol. 1, no. 1, pp. i–i, 2000
  48. Does insulin play a role in cardiovascular autonomic regulation?
    Diabetes Care, vol. 23, no. 6, pp. 724–725, 2000
  49. Insulin receptor in rat peripheral nerve: its localization and alternatively spliced isoforms
    Diabetes/Metabolism Research and Reviews, vol. 16, no. 5, pp. 354–363, 2000
  50. Diabetic neuropathy - a continuing enigma
    Diabetes/Metabolism Research and Reviews, vol. 16, no. 6, pp. 408–433, 2000
  51. A comparison of diabetic polyneuropathy in Type II diabetic BBZDR/Wor rats and in Type I diabetic BB/Wor rats
    Diabetologia, vol. 43, no. 6, pp. 786–793, 2000
  52. Experimental diabetic neuropathy: an update
    Diabetologia, vol. 42, no. 7, pp. 773–788, 1999
  53. Neuropathology of Chromosome-17-Linked Dementia
    Dementia and Geriatric Cognitive Disorders, vol. 10, no. Suppl. 1, pp. 61–63, 1999
  54. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes
    Current Eye Research, vol. 17, no. 3, pp. 301–307, 1998
  55. Progression Rates of Diabetic Neuropathy in Placebo Patients in an 18-Month Clinical Trial
    Journal of Diabetes and its Complications, vol. 12, no. 3, pp. 121–127, 1998
  56. Imbalances in N-CAM, SAM and polysialic acid may underlie the paranodal ion channel barrier defect in diabetic neuropathy
    Diabetes Research and Clinical Practice, vol. 40, no. 3, pp. 153–160, 1998
  57. Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin
    Neuron, vol. 19, no. 1, pp. 205–218, 1997
  58. Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats
    Diabetes Research and Clinical Practice, vol. 37, no. 2, pp. 109–120, 1997
  59. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats
    Gastroenterology, vol. 113, no. 5, pp. 1535–1544, 1997
  60. Evidence for a High Free Radical State in Low-grade Astrocytomas
    Neurosurgery, vol. 41, no. 5, pp. 1146–1151, 1997
  61. Diabetic neuropathies
    Diabetologia, vol. 40, no. 0, pp. S74–S77, 1997
  62. Clinical features of perineuritis
    Muscle & Nerve, vol. 20, no. 9, pp. 1153–1157, 1997
  63. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
    Annals of Neurology, vol. 41, no. 6, pp. 706–715, 1997
  64. Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions
    Annals of Neurology, vol. 39, no. 2, pp. 241–255, 1996
  65. Glial cytoplasmic inclusions in multiple system atrophy
    Annals of Neurology, vol. 39, no. 3, pp. 416–416, 1996
  66. The neuropathology of chromosome 17-linked dementia
    Annals of Neurology, vol. 39, no. 6, pp. 734–743, 1996
  67. Molecular basis of phenotypic variability in sporadc creudeldt-jakob disease
    Annals of Neurology, vol. 39, no. 6, pp. 767–778, 1996
  68. Glial and neuronal cytoplasmic inclusions in familial olivopontocerebellar atrophy
    Annals of Neurology, vol. 40, no. 5, pp. 819–820, 1996
  69. Differences between multiple system atrophy and olivopontocerebellar atrophy
    Annals of Neurology, vol. 40, no. 6, pp. 945–945, 1996
  70. Single-fiber electromyography in diabetic peripheral polyneuropathy
    Muscle & Nerve, vol. 19, no. 1, pp. 2–9, 1996
  71. Frequency of median mononeuropathy in patients with mild diabetic neuropathy in the early diabetes intervention trial (EDIT)
    Muscle & Nerve, vol. 19, no. 2, pp. 140–146, 1996
  72. Frequency of neuropathology in a brain bank from a long-term, domiciliary population
    Journal of Psychiatric Research, vol. 30, no. 1, pp. 45–49, 1996
  73. Increased regional brain concentrations of ceruloplasmin in neurodegenerative disorders
    Brain Research, vol. 738, no. 2, pp. 265–274, 1996
  74. Failure of nimodipine to prevent or correct the long-term nerve conduction defect and increased neuronal Ca2+-currents in the diabetic BB/W-rat
    Diabetes Research and Clinical Practice, vol. 32, no. 3, pp. 135–140, 1996
  75. Nerve fiber regeneration following axotomy in the diabetic biobreeding Worcester rat: The effect of ARI treatment
    Journal of Diabetes and its Complications, vol. 10, no. 4, pp. 183–191, 1996
  76. Nodal Na+-channel displacement is associated with nerve-conduction slowing in the chronically diabetic BB/W rat: Prevention by aldose reductase inhibition
    Journal of Diabetes and its Complications, vol. 10, no. 4, pp. 192–200, 1996
  77. Acetyl--carnitine deficiency as a cause of altered nerve myo-inositol content, Na,K-ATPase activity, and motor conduction velocity in the streptozotocin-diabetic rat*1
    Metabolism, vol. 45, no. 7, pp. 865–872, 1996
  78. Glucose transporters in rat peripheral nerve: Paranodal expression of GLUT1 and GLUT3*1
    Metabolism, vol. 45, no. 12, pp. 1466–1473, 1996
  79. [3H]methoxytetrabenazine: A high specific activity ligand for estimating monoaminergic neuronal integrity
    Neuroscience, vol. 68, no. 3, pp. 955–962, 1995
  80. Impaired recovery in diabetic rat nerve following anoxic conduction block
    Diabetes Research and Clinical Practice, vol. 25, no. 3, pp. 177–181, 1994
  81. Galactosemia produces ARI-preventable nodal changes similar to those of diabetic neuropathy
    Diabetes Research and Clinical Practice, vol. 25, no. 2, pp. 117–129, 1994
  82. Novel amyloid precursor protein gene mutation (codon 665Asp) in a patient with late-onset Alzheimer's disease
    Annals of Neurology, vol. 35, no. 4, pp. 432–438, 1994
  83. Paraneoplastic pseudo-obstruction, mononeuropathy multiplex, and sensory neuronopathy
    Muscle & Nerve, vol. 17, no. 1, pp. 91–96, 1994
  84. Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat
    Diabetologia, vol. 36, no. 7, pp. 608–614, 1993
  85. The preventive effect of aldose reductase inhibition on diabetic optic neuropathy in the BB/W-rat
    Diabetologia, vol. 36, no. 10, pp. 893–898, 1993
  86. The effect of acarbose on diabetes- and age-related basement membrane thickening in retinal capillaries of the BB/W-rat
    Diabetes Research and Clinical Practice, vol. 20, no. 2, pp. 123–128, 1993
  87. Effect of hyperglycemia and the aldose reductase inhibitor tolrestat on sural nerve biochemistry and morphometry in advanced diabetic peripheral polyneuropathy
    Journal of Diabetes and its Complications, vol. 7, no. 3, pp. 157–169, 1993
  88. Structure-function interactions in the therapeutic response of diabetic neuropathy
    Journal of Diabetes and its Complications, vol. 6, no. 1, pp. 64–68, 1992
  89. The effect of myo-inositol treatment on basement membrane thickening in the BB/W-rat retina
    Diabetes Research and Clinical Practice, vol. 16, no. 1, pp. 13–17, 1992
  90. Impaired visual evoked potential and primary axonopathy of the optic nerve in the diabetic BB/W-rat
    Diabetologia, vol. 35, no. 7, pp. 602–607, 1992
  91. The reproducibility and sensitivity of sural nerve morphometry in the assessment of diabetic peripheral polyneuropathy
    Diabetologia, vol. 35, no. 6, pp. 560–569, 1992
  92. Long-term suppression of postprandial hyperglycaemia with acarbose retards the development of neuropathies in the BB/W-rat
    Diabetologia, vol. 35, no. 4, pp. 325–330, 1992
  93. Case-of-the-month: Perineuritis presenting as mononeuritis multiplex
    Muscle & Nerve, vol. 15, no. 5, pp. 630–635, 1992
  94. Anionic sites in diabetic basement membranes and their possible role in diffusion barrier abnormalities in the BB-rat
    Diabetologia, vol. 34, no. 5, pp. 301–306, 1991
  95. Insulin-like growth factor-I expression is not increased in the retina of diabetic BB/W-rats
    Diabetes Research and Clinical Practice, vol. 14, no. 2, pp. 91–97, 1991
  96. Augmented polyol pathway activity and retinal pigment epithelial permeability in the diabetic BB rat
    Diabetes Research and Clinical Practice, vol. 8, no. 1, pp. 1–11, 1990
  97. The presence of anionic sites in basement membranes of cerebral capillaries
    Microvascular Research, vol. 39, no. 1, pp. 123–127, 1990
  98. Nerve growth factor (NGF), proNGF and NGF receptor-like immunoreactivity in BB rat retina
    Brain Research, vol. 523, no. 1, pp. 11–15, 1990
  99. Putrescine has anti-arrhythmic effects in rat models of arrhythmia
    Pharmacological Research, vol. 22, pp. 125–126, 1990
  100. The long-term effect of pancreatic islet allotransplantation on glomerular basement membrane thickening in experimental diabetes
    Journal of Diabetic Complications, vol. 3, no. 1, pp. 35–39, 1989
  101. Microcomputer collection and analysis of RR-interval data in the BB-rat
    Computers in Biology and Medicine, vol. 19, no. 6, pp. 443–452, 1989
  102. Diabetic and hypoglycemic neuropathy — a comparison in the BB rat
    Diabetes Research and Clinical Practice, vol. 6, no. 4, pp. 279–296, 1989
  103. Pancreatic islet allograft prevents basement membrane thickening in the diabetic rat retina
    Diabetologia, vol. 31, no. 3, pp. 175–181, 1988
  104. Pathogenetic heterogeneity in retinal capillary basement membrane thickening in the diabetic BB-rat
    Diabetologia, vol. 30, no. 12, pp. 966–968, 1987
  105. Aldose reductase in the BB rat: isolation, immunological identification and localization in the retina and peripheral nerve
    Diabetologia, vol. 30, no. 4, pp. 244–251, 1987
  106. Acinic cell carcinoma metastatic to the brain: Case report and ultrastructural study
    Head & Neck Surgery, vol. 10, no. 2, pp. 118–123, 1987
  107. Reversible and irreversible nodal dysfunction in diabetic neuropathy
    Annals of Neurology, vol. 21, no. 5, pp. 504–507, 1987
  108. Astroblastoma revisited: A report of three cases
    Acta Neuropathologica, vol. 70, no. 1, pp. 10–16, 1986
  109. Secretory Meningioma
    The American Journal of Surgical Pathology, vol. 10, no. 2, pp. 102–111, 1986